Collectively, these results strongly suggest that the activation of cGAS/STING signaling directly mediated the anti-tumor effects of PRMT3 KO or inhibition through activation of T cell-mediated anti-tumor immunity in HCC. The gene discussed is PRMT3; the disease is hepatocellular carcinoma.